Researchers at the National Institutes of Health and Yale School of Medicine, New Haven, Connecticut, report of the new findings is published in Molecular Psychiatry. Spironolactone is used in clinical practice as a diuretic and to treat conditions like heart problems and high blood pressure. The study presents converging evidence from experiments in mice and rats, as well as a cohort study in humans, suggesting that the medication may play a role in reducing alcohol drinking. Currently there are three medications approved for alcohol use disorder in the United States.Read Long Article
